TelesDystocia: Tele-Support vs. Cognitive Aid in Simulated Shoulder Dystocia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical University of Vienna

About this trial

Shoulder dystocia is an unpredictable, time-critical obstetric emergency requiring immediate recognition and rapid execution of established maneuvers. To date, there is no published evidence evaluating remote real-time support for the management of shoulder dystocia, which could be especially relevant for providers not frequently confronted with obstetric emergencies.

This prospective, randomized, controlled, simulation-based trial compares healthcare providers' performance in managing a standardized shoulder dystocia scenario when supported by remote tele-assistance versus a standard cognitive aid. Teams of at least two healthcare providers manage a standardized scenario on the Laerdal MamaBirthie Task Trainer, with a trained study team member playing the laboring patient. Successful delivery requires completion of three predefined external maneuvers and one internal maneuver.

Teams are randomized to Group A (cognitive aid: a standardized visual reference tool with written instructions and pictograms) or Group B (remote tele-support: live video guidance from a credentialed obstetric expert via Signal). The primary outcome is the total performance score (0-25 points). Secondary outcomes include cognitive load (NASA-TLX), usability (System Usability Scale), and subjective experience and communication quality (5-point Likert scales).

Eligibility criteria

Qualifiers

Adult healthy healthcare providers (paramedics, emergency physicians, midwives, nurses)

Working in teams of at least two persons

Fluent in German (the cognitive aid is provided in German)

Training in shoulder dystocia management (McRoberts, suprapubic pressure, Gaskin) in the preceding six months

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Remote Tele-Support
  • Cognitive Aid

Treatment groups

52 Participants
are divided into 2 treatment groups

Sponsors and collaborators